Updated Jul 16, 2026
Carley Brian T has filed 2 SEC Form 4 filings across 1 company in the last 90 days.
Brian T. Carley is a corporate director at Medpace Holdings, Inc., a contract research organization specializing in drug development and clinical trial services. He has been involved in various SEC filings related to his role at the company.
| Role | Director |
|---|---|
| Notability | 30/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-07-02 | MEDP | Medpace Holdings, Inc. | M — Option exercise | 36 | — | |
| 2026-04-02 | MEDP | Medpace Holdings, Inc. | M — Option exercise | 36 | — | |
| 2026-02-17 | MEDP | Medpace Holdings, Inc. | M — Option exercise | 6.5K | $54.99 | $356K |
| 2025-09-30 | MEDP | Medpace Holdings, Inc. | M — Option exercise | 62 | — | |
| 2025-06-30 | MEDP | Medpace Holdings, Inc. | M — Option exercise | 62 | — | |
| 2024-10-02 | MEDP | Medpace Holdings, Inc. | M — Option exercise | 78 | — |
Brian T. Carley is a corporate director at Medpace Holdings, Inc., a contract research organization specializing in drug development and clinical trial services. He has been involved in various SEC filings related to his role at the company.…
2 primary Form 4 filings in the last 90 days, covering 1 company.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Carley Brian T profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.